HCM
DXCM icon

Highlander Capital Management’s DexCom DXCM Stock Holding History

Highlander Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300
Closed -$22K – 615
2022
Q2 		$22K Sell
300
-100
-25% -$9.13K 0.01% 387
2022
Q1 		$51K Buy
+400
New +$43.8K 0.02% 289
2021
Q1 		– Sell
-400
Closed -$37K – 622
2020
Q4 		$37K Hold
400
– – 0.02% 320
2020
Q3 		$41K Buy
+400
New +$41.8K 0.02% 307
2020
Q2 		– Sell
-800
Closed -$54K – 608
2020
Q1 		$54K Buy
+800
New +$49.8K 0.04% 261

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Highlander Capital Management's DXCM Position: Q3 2022 in Review

Highlander Capital Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 300 shares — an estimated $22K sold.

Highlander Capital Management first reported a position in DXCM in Q1 2020 and held it in 5 quarters. The position peaked at $54K in Q1 2020. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Highlander Capital Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Highlander Capital Management sold 300 DexCom shares in Q3 2022, an estimated $22K.
  • Highlander Capital Management first reported a position in DexCom in Q1 2020 and held it in 5 quarters.
  • Highlander Capital Management's DexCom position peaked at $54K in Q1 2020.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Highlander Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.